Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

The Pyruvate Kinase (PK) Activator AG-946 Improves PK Properties and Red Blood Cell (RBC) Characteristics upon Ex Vivo treatment of RBCs from Patients with Myelodysplastic Syndromes

Jonathan R.A. De Wilde, Titine J.J. Ruiter, Brigitte A. van Oirschot, Judith J.M. Jans, Lenny Dang, Megan Wind-Rotolo, Noortje Thielen, Wouter W. van Solinge, Anna van Rhenen, Richard van Wijk, Minke A.E. Rab

Blood (2023) 142 (Supplement 1): 3222.

https://doi.org/10.1182/blood-2023-185772

Published: 2023

Journal Articles

Improved Gvhd-Relapse Free Survival of Ex Vivo αβtcr/CD19 Depleted Allo-Sct Combined with In Vivo T Cell Depletion with ATG When Compared to T Cell Replete Transplantations with or without the Addition of ATG

Moniek De Witte, Anniek Stuut, Klaartje Nijssen, Lotte Van Der Wagen, Anna Van Rhenen, Laura Daenen, Anke Janssen, Henk-Jan Prins, Kasper Westinga, Julia Drylewicz, Jurgen Kuball

Blood (2023) 142 (Supplement 1): 4931.

https://doi.org/10.1182/blood-2023-173621

Published: 2023

Journal Articles

First Results of a Prospective I/II Clinical Trial in Adult Patients Using TCR Alpha/Beta Depleted Stem Cell Transplantation from Matched Related and Unrelated Donors

Moniek De Witte, MD PhD, Anna Van Rhenen, MD PhD, Geerte Van Sluis, MD PhD, Rick Admiraal, MD PhD, Lotte van der Wagen, MD, Eefke J. Petersen, MD PhD, Reinier Raymakers, MD PhD, Monique C Minnema, MD PhD, Anke Janssen, MD, Kasper Westinga, BSc, Constantijn J.M. Halkes, MD, J.H. Frederik Falkenburg, MD PhD, Jaap Jan Boelens, MD PhD, Jurgen Kuball, MD

Blood (2018) 132 (Supplement 1): 2164.

https://doi.org/10.1182/blood-2018-99-112758

Published: 2018

Journal Articles

Rapidly progressive neurological deterioration without magnetic resonance imaging abnormalities: intravascular lymphoma

Anna van Rhenen, Niels W. C. J. van de Donk

Blood (2014) 123 (19): 2914.

https://doi.org/10.1182/blood-2014-01-549980

Published: 2014

Journal Articles

Expression of C-Type Lectin-Like Molecule-1 (CLL-1) on Stem Cells Might Discriminate De Novo Acute Myeloid Leukemia from Acute Myeloid Leukemia Originating from Myelodysplastic Syndromes

Theresia M Westers, PhD, Monique Terwijn, MSc, Canan Alhan, MD, Yvonne FCM van der Veeken, Claudia Cali, Angele Kelder, Anna van Rhenen, MD, PhD, Gerrit Jan Schuurhuis, PhD, Gert J Ossenkoppele, MD, PhD, Arjan A van de Loosdrecht, MD, PhD

Blood (2008) 112 (11): 2697.

https://doi.org/10.1182/blood.V112.11.2697.2697

Published: 2008

Journal Articles

Identification of a Small Subpopulation of Candidate Leukemia Initiating Cells within the Side Population (SP) of Patients with Acute Myeloid Leukemia.

Bijan Moshaver, Angele Kelder, Guus Westra, Anna van Rhenen, MD, Gert J. Ossenkoppele, MD, PhD, Sonja Zweegman, MD, PhD, Gerrit J. Schuurhuis, PhD

Blood (2007) 110 (11): 4120.

https://doi.org/10.1182/blood.V110.11.4120.4120

Published: 2007

Journal Articles

The novel AML stem cell–associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells

Anna van Rhenen, Guus A. M. S. van Dongen, Angèle Kelder, Elwin J. Rombouts, Nicole Feller, Bijan Moshaver, Marijke Stigter-van Walsum, Sonja Zweegman, Gert J. Ossenkoppele, Gerrit Jan Schuurhuis

Blood (2007) 110 (7): 2659–2666.

https://doi.org/10.1182/blood-2007-03-083048

Published: 2007

Journal Articles

In Acute Myeloid Leukemia Both Malignant and Normal Stem Cells Can Be Detected in Remission Bone Marrow.

Anna van Rhenen, Nicole Feller, PhD, Angele Kelder, Bijan Moshaver, Sonja Zweegman, PhD MD, Gert Ossenkoppele, PhD MD, Gerrit J. Schuurhuis, PhD

Blood (2006) 108 (11): 2537.

https://doi.org/10.1182/blood.V108.11.2537.2537

Published: 2006

Journal Articles

Identification of Primitive Subpopulations of Acute Myeloid Leukemia Side Population (SP) Stem Cells Defined by Differentiation Status and Malignant Character.

Bijan Moshaver, Marjolein A. van der Pol, PhD, Guus H. Westra, Nicole Feller, PhD, Angele Kelder, Anna van Rhenen, Gert J. Ossenkoppele, MD,PhD, Sonja Zweegman, MD,PhD, Gerrit J. Schuurhuis, PhD

Blood (2006) 108 (11): 2538.

https://doi.org/10.1182/blood.V108.11.2538.2538

Published: 2006

Journal Articles

Acute Myeloid Leukemia Remission Bone Marrow Reveals the Presence of Malignant and Normal Side Population (SP) Stem Cells Whose Frequencies and Ratios Predict Clinical Outcome.

Bijan Moshaver, Marjolein A. van der Pol, PhD, Guus H. Westra, Nicole Feller, PhD, Angele Kelder, Anna van Rhenen, Gert J. Ossenkoppele, MD,PhD, Sonja Zweegman, MD,PhD, Gerrit J. Schuurhuis, PhD

Blood (2006) 108 (11): 2314.

https://doi.org/10.1182/blood.V108.11.2314.2314

Published: 2006

Journal Articles

The Novel AML Stem Cell Associated Antigen CLL-1 Discriminates between Normal and Leukemic Stem Cells.

Anna van Rhenen, Nicole Feller, Angèle Kelder, Guus Westra, Lex Bakker, PhD, Gert Ossenkoppele, MD, PhD, Gerrit Jan Schuurhuis, PhD

Blood (2005) 106 (11): 4.

https://doi.org/10.1182/blood.V106.11.4.4

Published: 2005

NARROW

The Pyruvate Kinase (PK) Activator AG-946 Improves PK Properties and Red Blood Cell (RBC) Characteristics upon Ex Vivo treatment of RBCs from Patients with Myelodysplastic Syndromes

Improved Gvhd-Relapse Free Survival of Ex Vivo αβtcr/CD19 Depleted Allo-Sct Combined with In Vivo T Cell Depletion with ATG When Compared to T Cell Replete Transplantations with or without the Addition of ATG

First Results of a Prospective I/II Clinical Trial in Adult Patients Using TCR Alpha/Beta Depleted Stem Cell Transplantation from Matched Related and Unrelated Donors

Rapidly progressive neurological deterioration without magnetic resonance imaging abnormalities: intravascular lymphoma

Expression of C-Type Lectin-Like Molecule-1 (CLL-1) on Stem Cells Might Discriminate De Novo Acute Myeloid Leukemia from Acute Myeloid Leukemia Originating from Myelodysplastic Syndromes

Identification of a Small Subpopulation of Candidate Leukemia Initiating Cells within the Side Population (SP) of Patients with Acute Myeloid Leukemia.

The novel AML stem cell–associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells

In Acute Myeloid Leukemia Both Malignant and Normal Stem Cells Can Be Detected in Remission Bone Marrow.

Identification of Primitive Subpopulations of Acute Myeloid Leukemia Side Population (SP) Stem Cells Defined by Differentiation Status and Malignant Character.

Acute Myeloid Leukemia Remission Bone Marrow Reveals the Presence of Malignant and Normal Side Population (SP) Stem Cells Whose Frequencies and Ratios Predict Clinical Outcome.

The Novel AML Stem Cell Associated Antigen CLL-1 Discriminates between Normal and Leukemic Stem Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only